HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dormant origins, the licensing checkpoint, and the response to replicative stresses.

Abstract
Only ∼10% of replication origins that are licensed by loading minichromosome maintenance 2-7 (MCM2-7) complexes are normally used, with the majority remaining dormant. If replication fork progression is inhibited, nearby dormant origins initiate to ensure that all of the chromosomal DNA is replicated. At the same time, DNA damage-response kinases are activated, which preferentially suppress the assembly of new replication factories. This diverts initiation events away from completely new areas of the genome toward regions experiencing replicative stress. Mice hypomorphic for MCM2-7, which activate fewer dormant origins in response to replication inhibition, are cancer-prone and are genetically unstable. The licensing checkpoint delays entry into S phase if an insufficient number of origins have been licensed. In contrast, humans with Meier-Gorlin syndrome have mutations in pre-RC proteins and show defects in cell proliferation that may be a consequence of chronic activation of the licensing checkpoint.
AuthorsDebbie McIntosh, J Julian Blow
JournalCold Spring Harbor perspectives in biology (Cold Spring Harb Perspect Biol) Vol. 4 Issue 10 (Oct 01 2012) ISSN: 1943-0264 [Electronic] United States
PMID22904560 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cell Cycle Proteins
Topics
  • Animals
  • Cell Cycle Checkpoints
  • Cell Cycle Proteins (metabolism, physiology)
  • Congenital Microtia
  • DNA Damage
  • DNA Replication (physiology)
  • Ear (abnormalities)
  • Growth Disorders (genetics)
  • Humans
  • Mice
  • Micrognathism (genetics)
  • Models, Genetic
  • Patella (abnormalities)
  • Replication Origin (genetics, physiology)
  • Stress, Physiological

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: